In the last years, ambroxol was indicated as a hopeful chaperone therapy for Gaucher disease, however, ambroxol selectively binds to misfolded glucocerebrosidase, the enzyme deficient in Gaucher disease [121,122]. This evidence concerns the gene GBA1 and Gaucher disease.